The accelerated approval of oncologic drugs lessons from ponatinib

Vinay Prasad, Sham Mailankody

Research output: Contribution to journalArticle

42 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)353-354
Number of pages2
JournalJAMA - Journal of the American Medical Association
Volume311
Issue number4
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Adverse Drug Reaction Reporting Systems
Pyridazines
Government Regulation
Imidazoles
Drug Approval
United States Food and Drug Administration
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Antineoplastic Agents
Public Health
ponatinib

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The accelerated approval of oncologic drugs lessons from ponatinib. / Prasad, Vinay; Mailankody, Sham.

In: JAMA - Journal of the American Medical Association, Vol. 311, No. 4, 2014, p. 353-354.

Research output: Contribution to journalArticle

@article{dccc4c4fd9734094959de3a406895809,
title = "The accelerated approval of oncologic drugs lessons from ponatinib",
author = "Vinay Prasad and Sham Mailankody",
year = "2014",
doi = "10.1001/jama.2013.284531",
language = "English (US)",
volume = "311",
pages = "353--354",
journal = "JAMA - Journal of the American Medical Association",
issn = "0002-9955",
publisher = "American Medical Association",
number = "4",

}

TY - JOUR

T1 - The accelerated approval of oncologic drugs lessons from ponatinib

AU - Prasad, Vinay

AU - Mailankody, Sham

PY - 2014

Y1 - 2014

UR - http://www.scopus.com/inward/record.url?scp=84892701195&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892701195&partnerID=8YFLogxK

U2 - 10.1001/jama.2013.284531

DO - 10.1001/jama.2013.284531

M3 - Article

C2 - 24449310

AN - SCOPUS:84892701195

VL - 311

SP - 353

EP - 354

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0002-9955

IS - 4

ER -